Generation Bio (GBIO) EBITDA Margin (2023 - 2025)
Historic EBITDA Margin for Generation Bio (GBIO) over the last 3 years, with Q3 2025 value amounting to 346.05%.
- Generation Bio's EBITDA Margin fell 1512600.0% to 346.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 531.26%, marking a year-over-year increase of 2498700.0%. This contributed to the annual value of 662.49% for FY2024, which is 14759700.0% up from last year.
- As of Q3 2025, Generation Bio's EBITDA Margin stood at 346.05%, which was down 1512600.0% from 2745.62% recorded in Q2 2025.
- Generation Bio's 5-year EBITDA Margin high stood at 194.78% for Q3 2024, and its period low was 3536.7% during Q2 2023.
- Its 3-year average for EBITDA Margin is 1249.69%, with a median of 863.65% in 2024.
- Per our database at Business Quant, Generation Bio's EBITDA Margin soared by 30352400bps in 2024 and then crashed by -22441500bps in 2025.
- Generation Bio's EBITDA Margin (Quarter) stood at 1212.93% in 2023, then surged by 58bps to 514.37% in 2024, then soared by 33bps to 346.05% in 2025.
- Its EBITDA Margin stands at 346.05% for Q3 2025, versus 2745.62% for Q2 2025 and 280.68% for Q1 2025.